Here is a detailed answer on what happens when salbutamol is followed by propranolol:
Salbutamol Inhaler Followed by Propranolol Tablet (1 Hour Later)
The Core Problem: Direct Pharmacological Antagonism
These two drugs work at the same receptors but in opposite directions, making the combination dangerous:
| Drug | Class | Receptor Action | Effect |
|---|
| Salbutamol | Selective beta-2 agonist | Activates beta-2 receptors | Bronchodilation, airway opening |
| Propranolol | Non-selective beta-blocker | Blocks both beta-1 and beta-2 receptors | Bronchoconstriction, cardiac slowing |
What Happens Step-by-Step
After salbutamol inhaler (time 0):
- Beta-2 receptors in bronchial smooth muscle are activated
- Airways dilate, breathing improves
- Salbutamol's inhaled effect typically lasts 4-6 hours (short-acting)
After propranolol tablet (1 hour later):
Propranolol absorbs from the gut and blocks beta-2 receptors in the lungs directly - reversing the bronchodilation salbutamol just achieved. Multiple effects occur:
-
Bronchoconstriction / Bronchospasm - the most dangerous effect. Propranolol blocks the beta-2 receptors that salbutamol was stimulating. Airways narrow. This can be life-threatening in an asthma or COPD patient. As confirmed by authoritative textbooks: "Propranolol should not be used in asthmatics, or together with salbutamol and other selective beta-2 agonists." - Scott-Brown's Otorhinolaryngology Head & Neck Surgery
-
Bradycardia - propranolol's beta-1 blockade slows heart rate. Salbutamol at high doses can cause a mild tachycardia; propranolol will reverse this and potentially overshoot to bradycardia.
-
Antagonism of bronchodilatory rescue - because propranolol occupies the beta-2 receptors, further doses of salbutamol will have reduced or no effect. This is the most clinically dangerous scenario: a patient in bronchospasm reaches for their rescue inhaler and it doesn't work.
-
Hyperkalemia (mild risk) - Salbutamol shifts potassium into cells (lowering serum K+), while propranolol blocks this effect and may push serum K+ back up. This has implications for patients with cardiac or renal issues.
-
Masking of hypoglycemia signs - propranolol blocks tachycardia, which is one of the warning signs of low blood sugar (important if the patient is diabetic).
Who is at Greatest Risk?
- Asthma patients: Using salbutamol as a bronchodilator then taking propranolol can trigger a fatal asthma attack. This is a well-recognized absolute contraindication.
- COPD patients: Similar risk of severe bronchospasm.
- Healthy people: May tolerate small propranolol doses with some reduction in bronchodilator effect, but still at risk of bronchospasm at higher doses.
Harrison's Principles of Internal Medicine (2025) notes: "The earliest beta blocker drugs were relatively nonselective blockers of beta-adrenergic receptors, including the heart (beta-1 receptors) and lungs (beta-2 receptors). They are rarely prescribed [for certain conditions] due to the potential for bronchospasm."
Clinical Bottom Line
The combination of salbutamol + propranolol is contraindicated, especially in patients with asthma or reversible airway disease. Taking propranolol just 1 hour after salbutamol means:
- The propranolol will overcome and reverse the bronchodilation
- It can trigger severe, potentially fatal bronchospasm
- If bronchospasm occurs, salbutamol rescue doses will not work because propranolol is blocking the very receptors salbutamol needs
- Emergency treatment would require ipratropium (anticholinergic) or IV magnesium sulfate, not more salbutamol
If a patient genuinely needs both a beta-blocker and a bronchodilator (e.g., for cardiac reasons + asthma), a cardioselective beta-1 blocker (like metoprolol or bisoprolol) is used instead of propranolol - these have much less effect on lung beta-2 receptors.